Sarepta Therapeutics sales outlook dips after Q4 miss
The Sarepta Therapeutics sales outlook has been affected by challenges in commercializing its gene therapy, leading to decreased investor confidence and
Vinay Prasad Rejoins FDA as Top Vaccine and Gene Therapy Regulator After Shutdown
Vinay Prasad, the prominent researcher and former head of vaccine and gene therapy regulation at the U.S. Food and Drug Administration (FDA), is resuming his previous role after a brief…